Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate for painful diabetic peripheral neuropathy
2008-008753-33Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carisbamate in diabetic polyneuropathy (DPN) and Neuralgia (4 arms), sponsored by Johnson & Johnson. Primary endpoint: Mean of the last 7 Daily Average DPN Pain scores. Started Mar 2009; status: terminated.
02
Drugs
carisbamate
03
Conditions
diabetic polyneuropathy (DPN)Neuralgia
Beyond the preview
Go deeper on 2008-008753-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008753-33.